Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    Emergency services
    23 May 2025

    Enhancing public safety with reliable cellular coverage

    Enhancing Public Safety with Reliable Cellular Coverage In emergencies, every second counts. Reliable communication is vital for first responders to coordinate effectively and ensure public safety. However, many buildings suffer from poor cellular reception, hindering critical comm...

    Building twilight
    21 May 2025

    Wilson Connectivity launches WilsonPro Enterprise 5143U inbuilding cellular repeater for uk market

    Wilson Connectivity, a leader in wireless communication technology, recently announced the availability of the WilsonPro Enterprise 5143U in-building cellular repeater for the UK market. This powerful solution is certified to the Ofcom VTS testing standard, the gold standard developed b...

    USA
    16 May 2025

    Advantages of US manufacturing of telecom equipment

    As 5G becomes vital to national infrastructure, U.S.-based production offers security, supply chain control and long-term growth for America’s digital futureManufacturing the next generation of cellular telecommunications equipment within the United States offers numerous advantages, pa...

    logo
    13 May 2025

    Tozaro announces formation of Technical Advisory Board to support commercialization of Smart Polymers in cell and gene therapy bioprocessing

    World-class experts from bioprocessing and cell and gene therapy (CGT) fields include Phil Vanek PhD, Carl Schoellhammer PhD, Daniel C. Smith PhD and Nick Clarkson D.PhilBedfordshire, UK, 13 May 2025: Tozaro, an emerging technology provider in the field of cell and gene therapy manufact...

    ILD symptons
    13 May 2025

    Exploring treatment options for ILD

    Interstitial lung disease (ILD) refers to a group of lung disorders that cause inflammation and scarring of lung tissue, leading to progressive breathing difficulties. While there is currently no cure for ILD, treatment focuses on controlling symptoms, slowing disease progression, and i...

    ELRIG Logo
    7 May 2025

    ELRIG announces keynote speakers for Drug Discovery 2025

    Prof Heather Pinkett and Dr Dafydd Owen to lead ELRIG’s flagship event Drug Discovery returns to Liverpool, 21–22 October 2025 to celebrate “A Festival of Life Science”Event supported by VisitBritain showcases UK life science sector and extends international reachCambridge, UK, 07 May 2...

    logo
    7 May 2025

    PhoreMost makes key appointments to Board to advance development of next-generation degrader therapeutics

    Barbara Duncan joins as Chair and Stephen Dilly as Non-Executive DirectorStrategic appointments support progression of PhoreMost’s next generation degrader pipeline through preclinical development and commercialisation of its GlueSEEKER® platformCambridge, UK, 7 May 2025: PhoreMost...

    The Trilobio platform deck with a single pipette
    7 May 2025

    Trilobio raises $8M to deliver whole lab automation for biologists

    San Francisco, US, 06 May 2025: Trilobio, the Company building the fully automated robotic lab-in-a-box for biologists, announces it has raised $8 million USD Seed investment. The oversubscribed round was led by Initialized Capital, including participation from Argon Ventures and L...

    Simultaneous blood samples collected upstream and downstream of coronary plaque using the Liquid Biopsy System
    6 May 2025

    PlaqueTec announces positive early research findings from interim analysis in BIOPATTERN trial

    Pre-specified interim analysis reveals differences in protein concentration between systemic blood and blood from diseased coronary arteries Safety and functionality data for the updated Liquid Biopsy System supports continuation of the BIOPATTERN trial  ...

    Dr M Chen
    6 May 2025

    Nuclera establishes distribution network across APAC and the Middle East

    Operational expansion accelerates global distribution capability to increase regional access and technical supportMultiple partnerships establish direct distribution channels in China, Japan, South Korea, Singapore and IsraelCambridge, UK, and Boston MA, USA, 06 May 2025: Nuclera, the b...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 101
    • Page 102
    • Current page 103
    • Page 104
    • Page 105
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS